三酰甘油葡萄糖乘积指数对维持性血液透析患者腹主动脉钙化的评估价值
李新玉， 王雪荣， 袁亮， 包婷， 王德光 - 中国血液净化, 2023 - cjbp.org.cn
… Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations[J]…
dex is a useful marker for predicting subclinical coronary artery disease in the absence of …
dex is a useful marker for predicting subclinical coronary artery disease in the absence of …
血液透析患者心脏病变及超声检查在其诊断中的应用
李川， 龚德华 - 肾脏病与透析肾移植杂志, 2015 - njcndt.com
… annular calcification predicts mortality and coronary artery disease in end stage renal
disease.Atherosclerosis,… Cardiac valve calcification is a marker of vascular disease in prevalent …
disease.Atherosclerosis,… Cardiac valve calcification is a marker of vascular disease in prevalent …
[PDF][PDF] 重叠PCR 法构建XLRS1 三种不同类型突变体
王峰， 程海霞， 袁冬青， 夏鑫， 刘庆淮 - 现代生物医学进展, 2012 - biomed.cnjournals.com
… Quantity of inflammatory cells and smooth muscle cells in coronary artery plaque and its …
tor165 on progression of atherosclerotic plaque [J]. J Am Coll Cardiol, 2001, 37(8):2126-2130 …
tor165 on progression of atherosclerotic plaque [J]. J Am Coll Cardiol, 2001, 37(8):2126-2130 …
[HTML][HTML] 代谢相关脂肪性肝病肝外并发症研究进展与现状
池肇春 - 世界华人消化杂志, 2022 - wjgnet.com
… 试者的酒精和代谢相关病因的冠状动脉钙化(coronary artery calcium, CAC)评分与脂肪性肝病的
相关性… Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the …
相关性… Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the …
不同性别2 型糖尿病患者动脉粥样硬化指标的影响因素研究
林珍， 王琦， 周艳辉， 祝叶， 王康鸣 - 中国全科医学, 2021 - chinagp.net
… and irisin as predictive markers for atherosclerosis in Egyptian … smoking with subclinical
inflammation and atherosclerosis:… phosphatase relates to cardiovascular risk markers in children …
inflammation and atherosclerosis:… phosphatase relates to cardiovascular risk markers in children …
[HTML][HTML] 骨质疏松与动脉粥样硬化: 基于Ox-LDL 的转导作用
陈彩玲， 吴铁， 杨亚军， 崔燎 - 2020 - html.rhhz.net
… -LDL may be the key factor for atherosclerosis and osteoporosis.This provides a new
idea for drug research on the treatment of atherosclerosis and osteoporosis by regulating Ox-LDL. …
idea for drug research on the treatment of atherosclerosis and osteoporosis by regulating Ox-LDL. …
[HTML][HTML] KCNJ5 突变在醛固酮腺瘤心血管及代谢损害的临床进展
代若含， 王波 - Advances in Clinical Medicine, 2024 - hanspub.org
… Through this systematic review, we hope to provide a new perspective for clinical research
on the cardiovascular damage and metabolic complications resulting from KCNJ5 gene …
on the cardiovascular damage and metabolic complications resulting from KCNJ5 gene …
手术前腹主动脉钙化积分对新建动静脉内瘘失功的预测价值
庄峰， 仙淑丽， 王应灯 - 中国血液净化, 2022 - cjbp.org.cn
… [Abstract]Objective To observe the relationship between aortic calcification and primary …
possibility of predicting the dysfunction of autologous internal fistula by aortic calcification score. …
possibility of predicting the dysfunction of autologous internal fistula by aortic calcification score. …
[PDF][PDF] 缺血性卒中或短暂性脑缺血发作患者的卒中预防指南
RL Sacco, R Adams, G Albers, MJ Alberts… - 中华脑血管病 …, 2006 - sasg.com.cn
… 对辛伐他汀与安慰剂进 行比较的心脏保护研究(Heart Protection Study, HPS)证实了在
糖尿病患者中应用他汀类降脂药的 益处.在这项包括5 963 例年龄>40 岁,总胆固醇 >3.49 mmol/L(135 …
糖尿病患者中应用他汀类降脂药的 益处.在这项包括5 963 例年龄>40 岁,总胆固醇 >3.49 mmol/L(135 …
[HTML][HTML] 慢性肾脏病患者脑卒中的发生机制及治疗进展
刘佩， 钟玲 - Advances in Clinical Medicine, 2022 - hanspub.org
: 慢性肾脏病(Chronic kidney disease, CKD) 已成为快速增长的全球健康问题, 而CKD 患者脑
血管疾病所致的负担引起越来越多的关注. 因CKD 患者卒中后预后更差, 死亡率更高, 为肾脏病和…
血管疾病所致的负担引起越来越多的关注. 因CKD 患者卒中后预后更差, 死亡率更高, 为肾脏病和…